Aspen Neuroscience (ASPE) prices $140.6m IPO at $15 as Parkinson’s therapy enters pivotal development phase
Global Payments (GPN) jumps 13% on reported CD&R buyout talks, but $22bn debt burden complicates the deal
Read More Auto and Transport Industry News Insurance industry news Technology Industry News Why Roadzen’s FY2026 results matter for RDZN stock and AI-powered auto insurance Roadzen’s record FY2026 results sharpen RDZN’s AI insurance story with 42% Q4 revenue growth, narrower losses and a clearer profitability path. bySoujanya RaviJune 29, 2026